Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 6
1983 2
1984 1
1986 2
1987 1
1989 1
1992 3
1993 7
1994 12
1995 5
1996 7
1997 4
1998 10
1999 6
2000 7
2001 7
2002 8
2003 1
2004 6
2005 12
2006 18
2007 14
2008 14
2009 15
2010 10
2011 10
2012 15
2013 16
2014 24
2015 25
2016 24
2017 19
2018 27
2019 18
2020 23
2021 19
Text availability
Article attribute
Article type
Publication date

Search Results

360 results
Results by year
Filters applied: . Clear all
Page 1
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A, Matsumoto J, Hino M, Mataga N, Hayashi-Takagi A, Hashimoto K, Kunii Y, Kakita A, Yabe H, Yoshikawa T. Ohnishi T, et al. Among authors: toyoshima m. EBioMedicine. 2019 Jul;45:432-446. doi: 10.1016/j.ebiom.2019.05.062. Epub 2019 Jun 26. EBioMedicine. 2019. PMID: 31255657 Free PMC article.
Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology.
Ide M, Ohnishi T, Toyoshima M, Balan S, Maekawa M, Shimamoto-Mitsuyama C, Iwayama Y, Ohba H, Watanabe A, Ishii T, Shibuya N, Kimura Y, Hisano Y, Murata Y, Hara T, Morikawa M, Hashimoto K, Nozaki Y, Toyota T, Wada Y, Tanaka Y, Kato T, Nishi A, Fujisawa S, Okano H, Itokawa M, Hirokawa N, Kunii Y, Kakita A, Yabe H, Iwamoto K, Meno K, Katagiri T, Dean B, Uchida K, Kimura H, Yoshikawa T. Ide M, et al. Among authors: toyoshima m. EMBO Mol Med. 2019 Dec;11(12):e10695. doi: 10.15252/emmm.201910695. Epub 2019 Oct 28. EMBO Mol Med. 2019. PMID: 31657521 Free PMC article.
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study.
Suzuki Y, Karayama M, Uto T, Fujii M, Matsui T, Asada K, Kusagaya H, Kato M, Matsuda H, Matsuura S, Toyoshima M, Mori K, Ito Y, Koyauchi T, Yasui H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Suzuki Y, et al. Among authors: toyoshima m. J Thorac Oncol. 2020 Aug;15(8):1317-1327. doi: 10.1016/j.jtho.2020.04.002. Epub 2020 Apr 11. J Thorac Oncol. 2020. PMID: 32289515
Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Sumikawa H, Johkoh T, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Kamiya Y, et al. Among authors: toyoshima m. Respir Med. 2019 Nov;159:105811. doi: 10.1016/j.rmed.2019.105811. Epub 2019 Nov 5. Respir Med. 2019. PMID: 31710871
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, Jacobs S, Rizzo M, Peng L, Reyes D, Pinzon I, Fereira ME, Hunt V, Gore A, Toyoshima MT, Fonseca VA. Umpierrez GE, et al. Among authors: toyoshima mt. Diabetes Care. 2013 Aug;36(8):2169-74. doi: 10.2337/dc12-1988. Epub 2013 Feb 22. Diabetes Care. 2013. PMID: 23435159 Free PMC article. Clinical Trial.
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Fujisawa T, et al. Among authors: toyoshima m. Respirology. 2021 Apr;26(4):370-377. doi: 10.1111/resp.13978. Epub 2020 Nov 11. Respirology. 2021. PMID: 33179395 Free article.
Pulmonary Aspergilloma with Oxalosis.
Fukada A, Toyoshima M, Akahori D, Suda T. Fukada A, et al. Among authors: toyoshima m. Intern Med. 2018 Sep 15;57(18):2765-2766. doi: 10.2169/internalmedicine.0747-18. Epub 2018 Apr 27. Intern Med. 2018. PMID: 29709953 Free PMC article. No abstract available.
Benralizumab as initial treatment for chronic eosinophilic pneumonia.
Yazawa S, Toyoshima M, Koda K, Suda T. Yazawa S, et al. Among authors: toyoshima m. Allergol Int. 2021 Jan;70(1):140-142. doi: 10.1016/j.alit.2020.07.005. Epub 2020 Aug 14. Allergol Int. 2021. PMID: 32807690 Free article. No abstract available.
360 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page